US HB1032 | 2009-2010 | 111th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 123-45)
Status: Engrossed on November 15 2010 - 50% progression, died in chamber
Action: 2010-11-15 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on November 15 2010 - 50% progression, died in chamber
Action: 2010-11-15 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Text: Latest bill text (Engrossed) [PDF]
Summary
Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - (Sec. 2) Directs to the Comptroller General to study and report to specified congressional committees on the extent to which sponsors of clinical studies of investigational drugs, biologics, and devices and sponsors of applications for approval or licensure of new drugs, biologics, and devices comply with Food and Drug Administration (FDA) requirements and follow guidance for presentation of clinical study safety and effectiveness data by sex, age, and racial subgroups. Requires the Secretary of Health and Human Services (HHS) to submit to such committees a response to the the Comptroller General's report, including a corrective action plan as needed to respond to the recommendations in such report. (Sec. 3) Amends the Public Health Service Act to require the Secretary to report to Congress on the quality of, and access to, care for women with heart disease, stroke, and other cardiovascular diseases, including recommendations for eliminating disparities in, and improving the treatment of, heart disease, stroke, and other cardiovascular diseases in women. (Sec. 4) Expands and reauthorizes appropriations for FY2012-FY2016 for a program to award grants for preventive heath services and referrals for medical treatment for women through entities that are screening women for breast or cervical cancer.
Title
Heart Disease Education, Analysis Research, and Treatment for Women Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2010-11-15 | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | |
| 2010-09-30 | The title of the measure was amended. Agreed to without objection. | |
| 2010-09-30 | Motion to reconsider laid on the table Agreed to without objection. | |
| 2010-09-30 | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 9/28/2010 H7189-7190) | |
| 2010-09-30 | Considered as unfinished business. (consideration: CR H7380) | |
| 2010-09-28 | At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn. | |
| 2010-09-28 | DEBATE - The House proceeded with forty minutes of debate on H.R. 1032. | |
| 2010-09-28 | Considered under suspension of the rules. (consideration: CR H7189-7190) | |
| 2010-09-28 | Mr. Pallone moved to suspend the rules and pass the bill, as amended. | |
| 2010-09-28 | Placed on the Union Calendar, Calendar No. 379. | |
| 2010-09-28 | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-639. | |
| 2010-09-23 | Ordered to be Reported (Amended) by Voice Vote. | |
| 2010-09-23 | Committee Consideration and Mark-up Session Held. | |
| 2010-09-16 | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . | |
| 2010-09-16 | Subcommittee Consideration and Mark-up Session Held. | |
| 2010-09-15 | Subcommittee Hearings Held. | |
| 2009-02-13 | Referred to the Subcommittee on Health. | |
| 2009-02-12 | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB422 (Same As) 2009-02-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Cardiovascular and respiratory health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care quality
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Licensing and registrations
Medical education
Medical research
Prescription drugs
Women's health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care quality
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Licensing and registrations
Medical education
Medical research
Prescription drugs
Women's health
